News

Following our recent announcement that AliveDx had been shortlisted, we’re proud to confirm that we’ve now been officially recognised as one of the UK’s Best Workplaces in Biopharma with the list now published in The Guardian. This recognition places AliveDx among the top organisations in the country for workplace culture, innovation and employee wellbeing. The…

We’re proud to announce that AliveDx has been officially recognised as one of the UK’s Best Workplaces in BioPharma™ 2025 by Great Place to Work® UK. This is a prestigious honour that places us among the top 30 biopharma companies in the country. This recognition follows our earlier achievement of becoming Great Place to Work…

AliveDx Suisse S.A. (AliveDx) and Transmedic Indonesia, Thailand and Singapore have signed a second distribution agreement, enabling Transmedic to distribute the LumiQ® solution across these markets. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to expanding its global footprint and delivering clinical and economic value to clinicians, supporting faster diagnosis. Together, AliveDx…

AliveDx Suisse S.A. (AliveDx) and Vital Care Production Distribution et Logistique SPA (Vital Care), have signed a second distribution agreement, which will enable Vital Care to distribute the LumiQ® solution in Algeria. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to…

AliveDx Suisse S.A. (AliveDx) is pleased to announce the signing of a strategic distribution agreement with Medical Supplies and Services Co. Ltd. (MediServ). This agreement enables MediServ to distribute the MosaiQ® and LumiQ® solutions across Saudi Arabia, with immediate effect. This partnership marks a significant step in AliveDx’s ongoing commitment to expanding its presence in…

We’re proud to announce that AliveDx has achieved recertification to ISO 14001, the international standard for Environmental Management Systems (EMS). This milestone demonstrates our ongoing commitment to reducing environmental impact, improving sustainability, and maintaining operational excellence. ISO 14001 is especially important in the medical device industry, where responsible chemical handling, waste reduction, and energy efficiency…

AliveDx is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at AliveDx. Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.…

AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L. have signed two strategic distribution agreements, which will enable Warba Medical Supplies to distribute the MosaiQ® and LumiQ® solutions in Kuwait. The distribution agreements take effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding…

AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, have signed a distribution agreement, which will enable Bio-Strategy to distribute the LumiQ™ solution in Australia and New Zealand. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding in faster…

We are excited to announce our participation in the upcoming EuroMedLab Congress in Brussels, Belgium, from 19-22 May 2025. Visit us at booth #245 to learn more about our MosaiQ® and LumiQ™ innovative, turnkey, fully automated autoimmune diagnostic solutions. The MosaiQ solution is a groundbreaking IVD platform for autoimmune diseases, allergies, and beyond. Its multiplexed,…